首页> 外文期刊>Organic letters >Conformationally Constrained Analogues of Diacylglycerol. 24. Asymmetric Synthesis of a Chiral (R)-DAG-Lactone Template as a Versatile Precursor for Highly Functionalized DAG-Lactones
【24h】

Conformationally Constrained Analogues of Diacylglycerol. 24. Asymmetric Synthesis of a Chiral (R)-DAG-Lactone Template as a Versatile Precursor for Highly Functionalized DAG-Lactones

机译:二酰基甘油的构象约束类似物。 24.手性(R)-DAG-内酯模板作为高度功能化DAG-内酯的通用前体的不对称合成

获取原文
获取原文并翻译 | 示例
           

摘要

Commercially available 2-methylenepropane-1,3-diol was converted to chiral epoxide (R)-2 via Sharpless asymmetric epoxidation in >96% ee. Regiospecific epoxide ring opening and reduction of the intermediate alkyne set the stage for a one-pot lactonization to give (R)-6, a convenient precursor for all functionalized chiral DAG-lactones used as potent PK-C ligands. The synthesis of the most potent DAG-lactones known to date, (Z)-10 and (E)-10, served to confirm PK-C's exclusive preference for the (R)-stereochemistry in this class of compounds.
机译:通过在> 96%ee中通过Sharpless不对称环氧化将可商购的2-亚甲基丙烷-1,3-二醇转化为手性环氧化物(R)-2。区域特异性环氧化物的环的开环和中间体炔的还原为单锅内酯化提供了阶段,以得到(R)-6,这是用作有效PK-C配体的所有官能化手性DAG内酯的便利前体。迄今为止已知的最有效的DAG内酯(Z)-10和(E)-10的合成,证实了PK-C在此类化合物中对(R)-立体化学的排他性偏好。

著录项

  • 来源
    《Organic letters》 |2004年第14期|p. 2413-2416|共4页
  • 作者单位

    Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702;

    Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702;

    Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702;

    Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702;

    Laboratory of Cellular Carcinogenesis & Tumor Promotion, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892;

    Laboratory of Cellular Carcinogenesis & Tumor Promotion, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892;

    Laboratory of Cellular Carcinogenesis & Tumor Promotion, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892;

    Laboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, Shinlin Dong, Kwanak-ku, Seoul 151-742, South Korea;

    Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 有机化学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号